Portfolio

Accuri Cytometers

Accuri develops and manufactures revolutionary, low-cost, high-performance flow cytometers for researchers.

The company was acquired by BD (Becton, Dickinson and Company) on March 18, 2011 for an undisclosed sum. According to Xconomy, this acquisition represented the first cash return on investment for InvestMichigan! Growth Capital Fund, which invests in Michigan companies, and generated a return at 4.5 times the fund’s investment in Accuri.

Back

Company Profile

Accuri Cytometers Logo

Flagship Partners:

  • Harry Wilcox, Chief Operating Officer & General Partner